A5239 - A Pilot Study of Therapy with Pioglitazone Prior to Hepatitis C (HCV) Treatment in HIV-1 and
HCV Genotype 1-Infected Subjects with Insulin Resistance Who Are Prior Nonresponders to Peginterferon and Ribavirin
Therapy (PIO PRE-C)
Study Status: Coming soon.